Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
The UK Department of Health and Social Care (DHSC) has announced its anticipated 2025 headline payback rate for new medicines…
Pricing and Market Access
Denmark’s HTA evolution
Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate
South Korean pricing reform suggests more flexible drug reimbursement negotiations
Keytruda and Opdivo: a decade review
US negotiations for first round of drugs reveal $6bn in Medicare savings
Colombia’s president signs law to strengthen pharmaceutical sector
Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy
